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Hematopoietic stem cells (HSCs) undergo rapid expansion in re-
sponse to stress stimuli. Here we investigate the bioenergetic
processes which facilitate the HSC expansion in response to in-
fection. We find that infection by Gram-negative bacteria drives an
increase in mitochondrial mass in mammalian HSCs, which results in
a metabolic transition from glycolysis toward oxidative phosphor-
ylation. The initial increase in mitochondrial mass occurs as a result
of mitochondrial transfer from the bone marrow stromal cells (BMSCs)
to HSCs through a reactive oxygen species (ROS)-dependentmechanism.
Mechanistically, ROS-induced oxidative stress regulates the opening
of connexin channels in a system mediated by phosphoinositide 3-
kinase (PI3K) activation, which allows the mitochondria to transfer
from BMSCs into HSCs. Moreover, mitochondria transfer from BMSCs
into HSCs, in the response to bacterial infection, occurs before the
HSCs activate their own transcriptional program for mitochondrial
biogenesis. Our discovery demonstrates that mitochondrial transfer
from the bone marrow microenvironment to HSCs is an early phys-
iologic event in themammalian response to acute bacterial infection
and results in bioenergetic changes which underpin emergency
granulopoiesis.
ROS | infection | mitochondria | hematopoietic stem cell | PI3K
The lifelong maintenance of hematopoiesis is dependent onthe ability of hematopoietic stem cells (HSCs) to self-renew
and differentiate into all subtypes of mature blood cells (1, 2).
Hematopoiesis, however, is dynamic, and the HSCs, while pre-
dominantly quiescent, rapidly enter the cell cycle upon exposure to
specific stimuli. Rapid expansion of leukocytes in response to path-
ogens underpins the mammalian response to infection. Presently, the
mechanisms by which HSC metabolism is regulated in response to
the challenges of pathogenic stress are not fully understood.
HSCs reside in a specialized niche within the bone marrow (BM)
microenvironment (3). The BM microenvironment regulates the
production of both hematopoietic and nonhematopoietic cells for
the maintenance of blood production under normal and stressed
conditions (3, 4). HSCs reside in a hypoxic niche, and studies sug-
gest that quiescent HSC favor anaerobic glycolysis to generate the
energy required for cell maintenance under baseline conditions (5,
6). Furthermore, quiescent HSCs have also been reported to pos-
sess low mitochondrial mass (5, 7, 8), sustained by active elimination
of mitochondria through mitophagy, which has been suggested to be
critical for HSC maintenance (8, 9). However, a more recent study
shows that mitochondrial mass in HSCs is stable throughout their
life span, while mitochondrial turnover capacity is in fact lower in
HSCs than in progenitors (10). In addition to regulation of mito-
chondrial mass, the maintenance of HSC quiescence requires the
limiting of mitochondrial respiration (11). Reactive oxygen species
(ROS) levels, related to mitochondrial activity, are much lower in
the HSCs compared to the committed progenitors (12). Taken to-
gether, the baseline maintenance of HSC quiescence depends on a
set of specific metabolic conditions regulated in the HSC niche.
Pathogens have been a significant selective pressure in the
history of mammalian evolution and remain a leading cause of
global mortality (13). In response to infection HSCs require a
swift metabolic switch from glycolysis to mitochondrial oxidative
phosphorylation (OXPHOS) (14). This switch allows for some of
the HSCs to rapidly cycle and differentiate into the required
progenitor cells while other HSCs are maintained in the multi-
potent state. Increasing ROS levels, as in response to stress in-
fection, promote the differentiation of a subset of HSCs whereas
low levels of ROS maintain quiescence (15). HSC expansion
favors the utilization of OXPHOS as the principal energy source
in contrast to quiescent cells which favor glycolysis; accordingly,
the changes in cellular metabolism from dormant to cycling is
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clearly of fundamental importance for determining HSC fate
(16). This implies that differentiation of HSCs requires meta-
bolic conditions that include oxidative stress as well as a rapid
burst of energy supplied via mitochondrial OXPHOS.
Previously, we and others have shown that mitochondria can
transfer from bone marrow stromal cells (BMSCs) to acute mye-
loid leukemia (AML) blasts to enhance their proliferation in vitro
and in vivo through a mechanism which increases OXPHOS in the
leukemic blasts (17, 18). Moreover, as part of that study we ob-
served that human CD34+ hematopoietic progenitor cells (HPCs)
could also acquire mitochondria from BMSCs under oxidative
stress (17), leading us to hypothesize that the mitochondrial
transfer-dependent metabolic switch in AML has its “origins” in
the physiology of the HSC response to infection.
Most cases of invasive nontyphoidal Salmonella infection are
caused by Salmonella typhimurium (S. typhimurium), and invasive
strains of nontyphoidal salmonellae have emerged as a prominent
cause of bloodstream infection in African adults and children, with
an associated case fatality of 20 to 25% (19). In the context of the
challenge of acute bacterial infection, the hematopoietic system
needs to drive rapid HSC and leukocyte expansion, necessary for
host survival (20). Therefore, through studies using S. typhimurium
and its outer membrane lipopolysaccharide (LPS) to model acute
bacterial infection, we aim to understand if and how the mamma-
lian response to infection involves the acquisition of mitochondria
by HSC from cells within the BM microenvironment and the
mechanisms and processes by which this facilitates the bio-energetic
and oxidative changes required for rapid leukocyte generation.
Results
Mitochondria Are Transferred from the BM Microenvironment to
the HSC Populations In Vivo in Response to LPS. To determine if
mitochondria are transferred to HSCs in conditions of stressed
hematopoiesis, we used a humanized nonobese diabetic (NOD)
severe combined immunodeficiency (SCID) Il2rg knockout
NOD.Cg.PrkdscidIL2rgtm1Wji/SzJ (NSG) mouse model to assess
mitochondrial transfer from mouse BM to human CD34+ HSCs,
employing species-specific mitochondrial DNA (mtDNA) de-
tection as a surrogate tracker as previously shown (21). Humanized
(Hu)-NSG mice were created (Fig. 1 A and B) and were then
treated with LPS for 2 h. Animals were then killed and human
multipotent progenitors (MPPs), HSCs, and granulocyte macro-
phage progenitors (GMPs) were isolated and analyzed for the
presence of mouse mtDNA (Fig. 1 C and D). SI Appendix, Fig.
S1 A and B, confirms engraftment of human CD34+ HSCs in re-
cipient NSG mice. Fig. 1C shows that mouse mtDNA is signifi-
cantly increased in MPPs and HSCs but not in GMPs from LPS-
treated C57BL/6 hu-NSG mice. Fig. 1D confirms mitochondrial
mass increase in MPPs and HSCs from LPS-treated C57BL/6 mice.
As a second model to confirm transfer of mtDNA, we used
NSG (CD45.1: recipient) animals transplanted with C57BL/6
lineage-negative cells (CD45.2: donor) (Fig. 1E). Sanger se-
quencing of the mtDNA from NSG and C57BL/6 mice identified
2 single-nucleotide polymorphisms (SNP) that exist in the mi-
tochondrial genomes and which are capable of distinguishing the
2 murine strains (Fig. 1F and SI Appendix, Fig. S2 A and B). SI
Appendix, Fig. S1 C and D, confirmed engraftment of the donor
(CD45.2) in the recipient (CD45.1). SNP analysis of sorted
Lineage−Sca-1+c-Kit+ (LSK) cells and HSCs (lin−, Sca-1+,
c-Kit+, CD48−, CD150+) showed that transfer of mitochondrial
DNA from recipient to donor cells had occurred in vivo in LPS-
treated animals (Fig. 1 G and H). Together, these 2 animal
models confirm that mitochondrial DNA is transferred from the
BM microenvironment to HSC populations.
S. typhimurium Infection Increases Mitochondrial Potential and
Expansion of HSCs. To confirm that mitochondrial mass increases
in HSC populations in response to S. typhimurium MitoTracker
Green (MTG) and mtDNA mass measured by RT-PCR, were
used (Fig. 2A). C57BL/6 mice at 8 wk of age were infected with S.
typhimurium for 72 h, and HSCs showed an increase in MTG
fluorescence and mtDNA (Fig. 2 B and C). Fig. 2D confirms the
HSC expansion at 2 h post LPS treatment, and Fig. 2E shows
expansion of the GMP. Seahorse metabolic flux analysis measur-
ing oxygen consumption rates (OCR) confirmed increased oxi-
dative phosphorylation levels in LSK from LPS (2 h) and S.
typhimurium-treated (72 h) C57BL/6 mice (Fig. 2F). Extracellu-
lar acidification rate, which is a method to monitor glycolysis, was
not significantly up-regulated (SI Appendix, Fig. S3). Fig. 2G
shows increased tetramethylrhodamine, methyl ester (TMRM)
staining in LPS-treated LSK cells and HSCs in response to LPS,
indicating increased mitochondrial activity in these cells. The
messenger RNA (mRNA) expression of mitochondrial transcrip-
tion factor A (TFAM), which is a regulator of mitochondrial
biogenesis, was not up-regulated by 2 h post LPS stimulation (Fig.
2H). Together, these data confirm that infection with Gram-
negative bacteria increases mitochondrial content and function
in the HSC population; however, this was not associated with in-
creased mitochondrial biogenesis in HSCs.
Superoxide Drives Mitochondrial Transfer to HSCs. In previous work
we have reported that transfer of functional mitochondria from
the BM to AML is driven by AML-derived NADPH oxidase 2
(NOX2)-dependent ROS (17). We used the Amplex Red assay to
determine if superoxide is elevated in C57BL/6 BM of S. typhi-
murium and LPS-treated animals. Amplex Red reacts with H2O2
to produce a fluorescent signal, and, following inoculation of an-
imals with either S. typhimurium (72 h) or LPS (2 h), we observed
an increase in H2O2 in the BM of the C57BL/6 mice (Fig. 3A and
SI Appendix, Fig. S4A). Moreover, ROS (measured by H2DCFDA
fluorescence) was elevated in the LSK and HSC populations from
S. typhimurium (72 h) and LPS (2 h) treated C57BL/6 mice
compared to control animals (Fig. 3B and SI Appendix, Fig. S4B).
Next, to confirm ROS as the stimulus for mitochondrial trans-
fer, we treated mice with L-buthionine-sulfoximine (BSO) as
previously described, to mimic a rise in intracellular ROS con-
centrations in vivo but in the absence of infection (20). The dose
of BSO was selected to induce an increase in intracellular ROS in
LSK cells and HSCs at levels comparable to those that we ob-
served in LPS and S. typhimurium-induced ROS elevation (Fig.
3C). We found that mitochondrial content was increased in LSK
and HSC populations in BSO-treated mice compared to controls
(Fig. 3D). Next, Hu-NSG animals were treated with BSO for 2 h,
and then human MPPs and HSCs were isolated and analyzed for
mouse mtDNA (Fig. 3E). Fig. 3F shows that mouse mtDNA is
significantly increased in the human MPPs and HSCs from BSO-
treated Hu-NSG mice. For further assurance that ROS mediates
LPS-driven mitochondrial content increase in HSCs, we repeated
the experiments in Fig. 3 E and F, this time using the ROS
scavenger N-acetyl-cysteine (NAC) to reduce ROS levels.
Treatment with NAC suppressed LPS-induced mitochondrial
content increase in the LSK and HSC populations and led to a
reduced level of ROS in the LSK and HSC populations (SI
Appendix, Fig. S5 A and B). To determine if the ROS was de-
rived from NOX2, we investigated LPS-induced mitochondrial
transfer in the chronic granulomatous disease (CGD) mouse
model, in which the gp91 subunit of NOX2 has been deleted
(22). We found that LPS did not increase mitochondrial content
in HSCs in the gp91 knockout CGD mice (SI Appendix, Fig. S6 A
and B). Together, these data show that ROS is a signal which
mediates mitochondrial transfer from the BM microenvironment
to HSC populations.
BMSCs but Not Osteoblasts or Macrophages Donate Their Mitochondria
to HSCs in Response to Infection. Multiple cell types make up the
BM microenvironment (17); moreover, mitochondrial transfer
2 of 10 | www.pnas.org/cgi/doi/10.1073/pnas.1913278116 Mistry et al.
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from BMSCs to pulmonary alveoli has been shown to protect
against acute lung injury (23). Therefore, we investigated which
cells of the BM transfer their mitochondria to HSCs during
stressed hematopoiesis (Fig. 4A and SI Appendix, Fig. S7). Fig. 4B
shows that BMSCs transfer mitochondria to HSCs in vitro when
cultured in the presence of H2O2. There was no increase in mi-
tochondrial transfer from the macrophage or osteoblast when
cultured with H2O2 (Fig. 4 C and D). We infected primary mouse
BMSCs (mBMSCs) with an rLV.EF1.mCherry lentivirus for stable
production of mitochondria-incorporated mCherry-tagged protein,
and then lineage-negative cells transduced with rLV.EF1.AcGFP-
Mem9 lentivirus (enabling stable labeling of the cell membrane)
were cocultured with the rLV.EF1.mCherry mBMSCs for 24 h in
the presence or absence of H2O2. Fig. 4E shows that, upon the
coculture, the lineage-negative cells acquire the mitochondria-
incorporated mCherry fluorescence in the presence of H2O2.
Quantification of lineage-negative cells positive for rLV.EF1.m-
Cherry is shown in Fig. 4F. H2O2 treatment of lineage-negative
BMSC cocultures did not induce significant apoptosis (Fig. 4G).
To determine if infection induced ROS in BMSCs in vivo, we
analyzed ROS levels in BMSCs using H2DCFDA (Fig. 4H). Elevated
ROS levels were detected in BMSCs from LPS-treated C57BL/6
Fig. 1. Mitochondria are transferred from the BM microenvironment to the HSC populations in vivo in response to LPS. (A) Schematic diagram of experi-
mental design. Post engraftment hu-NSG mice were injected with LPS for 2 h. (B) The BM was extracted, and the cells were analyzed by flow cytometry or
sorted for hHSC (mCD45−, hCD34+, hCD38−, hCD45RA−, hCD90+, hCD49f+), hMPP (mCD45−, hCD34+, hCD38−, hCD45RA−, hCD90−, hCD49f−), and hGMP
(mCD45−, hCD34+, hCD38+, hCD45RA+, hCD90−, hCD49f−) cell populations using FACS. (C) mtDNA transfer was quantified using Taqman qPCR with species-
specific probes. Bars represent the percentage of mouse mtDNA in the hHSC, hMPP, or hGMP cells after 2 h treatment with LPS versus the control (untreated
cells). Human genomic DNA was used to standardize mtDNA. Data shown are means ± SD of n = 5 mice. *P < 0.05. (D) Flow cytometry analysis of MTG
fluorescence was assessed in the progenitor cells to quantify mitochondrial content. (E) Schematic diagram of experimental design. Recipient CD45.1 NSG
mice were treated with busulfan prior to tail-vein injections of lineage-negative CD54.2 C57BL/6 donor cells. One month post engraftment mice were treated
with LPS or vehicle PBS for 2 h. BM was isolated and sorted for donor LSK (Lin−, Sca-1+, c-Kit+) and donor HSC (Lin−, Sca-1+, c-Kit+, CD48−, CD150+) cell
populations expressing CD45.2 using FACS. The sorted donor cells were analyzed for specific donor or host mtDNA by TaqMan PCR using ND3 or COX3 probes
designed to detect strain-specific SNPs in the mitochondrial genome. (F) SNP differences in mtDNA between NSG mice and C57BL/6 mice. (G) The percentage
of recipient mtDNA in donor cells after a 2-h treatment with LPS versus control (untreated) cells using the COX3 TaqMan probe. (H) The percentage of
recipient mtDNA in donor cells after a 2-h treatment with LPS versus control (untreated) cells using the ND3 TaqMan probe. Donor genomic DNA was used to
standardize mtDNA copy number. Data shown are means ± SD of n = 5 mice. *P < 0.05; **P < 0.01; ***P < 0.001.
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compared to control animals (Fig. 4I). Moreover, mitochondrial
levels were reduced in the BMSCs of LPS-treated C57BL/6
compared to control animals, and this reduction was inhibited by
the addition of NAC (Fig. 4J). Using both in vitro and in vivo
modeling, these results show that BMSCs are the source of the
majority of mitochondria transferred to LSK cells and HSCs in
stress hematopoiesis.
PI3K Activates Connexin 43 Gap Junctions to Enable Mitochondrial
Movement by Phosphorylation of AKT. It has been reported that
mitochondria can be transferred intracellularly through gap
junctions (24). We therefore investigated whether gap junctions
regulated the transfer of mitochondria into HSCs in response to
LPS. To determine if gap junctions are involved in intercellular
communication between the HSCs and the BMSCs, we used the
mobile dye calcein (25, 26). Fig. 5A shows that calcein flows from
the BMSC into the HSC in the presence of H2O2 versus the
control. This transfer of calcein dye was reduced when the
BMSCs were cultured in the presence of the gap junction in-
hibitor carbenoxolone before the H2O2 treatment. Fig. 5B shows
that there is also a significant decrease in mtDNA transfer from
the BMSCs to the HSCs in vitro when cultured in the presence of
carbenoxolone and H2O2 compared to H2O2 alone. To establish
if the increase in mitochondrial content in the HSCs after
treatment with LPS is regulated by CX43 gap junctions in vivo, we
injected C57BL/6 mice with the gap junction inhibitor carbenox-
olone before LPS administration and compared them to C57BL/6
mice treated with LPS alone. We observed a decrease in the mi-
tochondrial content within the HSC population when pretreated
with carbenoxolone before LPS compared to the animals treated
with LPS alone (Fig. 5C). To further evaluate the role of CX43
gap junctions in mitochondrial transfer from BMSCs to HSCs, we
used the peptide inhibitor of CX43, GAP27. Immunofluorescent
images show that CX43 is expressed in both BMSCs and HSCs
and is colocated in the area of mitochondrial transfer, which is
inhibited further in the presence of GAP27 (Fig. 5 D and E). Movies
S1 and S2 show z-stacks which confirm that the rLV.EF1.mCherry is
inside the lineage-negative cells and not on the cell membrane in
the H2O2-treated cells but also not in the GAP27 and the H2O2-
treated cells. Fig. 5F shows that there is also a significant de-
crease in mtDNA transfer from the BMSCs to the HSCs in vitro
when cultured in the presence of GAP27 and H2O2 compared to
H2O2 alone. Taken together, including methods to inhibit gap
junctions, these data show that CX43 gap junctions mediate
transfer of mitochondria from the BM microenvironment to
HSC populations in models of stress hematopoiesis.
It has previously been shown that increased ROS levels are
associated with an increase in the signaling of phosphoinositide-
3,4,5-trisphosphate (PIP3) via oxidation of PTEN and subsequent
activation of PI3K (27–29). PIP3 activates the downstream sig-
naling component protein kinase AKT, which is required for cell
growth and survival (29). Therefore, we looked at AKT phos-
phorylation (S473) in the BMSCs and HSCs after LPS treatment.
Fig. 6 A and B showed that AKT phosphorylation was elevated in
both the BMSCs and the HSCs of LPS-treated animals when
compared to the untreated controls. BSO treatment also induced
AKT phosphorylation in both HSCs and BMSCs (Fig. 6C). Fig.
6D shows increased phosphorylation of AKT (pAKT-S473) in the
lineage-negative cells cocultured with BMSCs in the presence of
H2O2. Fig. 6E shows that H2O2-induced transfer of calcein dye to
lineage-negative cells was inhibited when the BMSCs were cul-
tured in the presence of CAL-101 [inhibitor of PI3 kinase delta
(PI3Kδ)]. Moreover, CAL-101 decreased mitochondrial transfer
from the BMSCs to HSCs in vitro (Fig. 6F). C57BL/6 mice pre-
treated with CAL-101 resulted in a decrease in mitochondrial
content within the HSC population in response to LPS (Fig. 6G).
Finally, to determine the impact of PI3Kδ inhibition on S. typhi-
murium infection, mice were infected with S. typhimurium for 5
d and treated daily with CAL-101. At day 5, surviving animals
were killed and histopathological analysis of liver sections showed
increased infection associated with liver injury in CAL101-treated
mice as evidenced by areas of hepatocellular death and immune
cell infiltration (Fig. 6H). Accordingly, further analysis showed
increased bacterial colony-forming units (CFUs) in CAL101-
treated livers after Salmonella infection (Fig. 6I). Results show
that inhibition of PI3Kδ renders the immune system less capable
of fighting S. typhimurium infection. Taken together, these data
indicate that PI3K signaling regulates mitochondrial transfer from
BMSCs to HSCs through a pAKT- and CX43-dependent mech-
anism without which the immune response to acute bacterial
infection is compromised.
Conclusions
Here we report that HSCs acquire mitochondria from BMSCs within
the protective BM microenvironment in response to acute bacte-
rial infection. This process facilitates a rapid shift within the HSCs
from the baseline, quiescent state—glycolytic metabolism—toward
OXPHOS, which is subsequently followed by leukocyte ex-
pansion. Mitochondria transfer occurs early in the mammalian
response to infection, preceding the onset of the transcriptional
Fig. 2. S. typhimurium infection increases mitochondrial potential and ex-
pansion of HSC. (A) Schematic of in vivo experiment in which C57/Bl6 mice
were infected with S. typhimurium (Sal) for 72 h and analyzed for HSC by
flow cytometry and PCR. (B) MTG fluorescence was assessed in the HSC cells
by flow cytometry. (C) mtDNA analysis of the HSC population sorted (Lin−,
Sca-1+, c-Kit+, CD48−, CD150+) from control and S. typhimurium treated
mice. (D) Percentage of cycling HSC as measured by Ki67-positive cells after
16 h of LPS treatment. Number of HSC after 16 h of LPS treatment. (E) BM
was isolated from control and LPS-treated animals at 2 h. BM cells (1 × 104)
were seeded in a semisolid Methocult for 7 d. Granulocytic progenitor (G),
granulocyte monocyte progenitor (GM), and granulocyte monocyte mega-
karyocyte progenitor (GEMM) colonies were then counted. (F) OXPHOS
levels were measured by OCR in freshly isolated LSK from control, LPS, and S.
typhimurium treated mice. (G) C57BL/6 mice were subjected to LPS or control
PBS i.p. injections. After 2 h the mice were killed, and the BM was extracted.
The populations were analyzed by flow cytometry for mean TMRM fluo-
rescence intensity within each population. (H) LSK were FACS-sorted from
control and LPS-treated animals, RNA was analyzed for TFAM gene expres-
sion. Data shown are means ± SD of n = 5 mice. *P < 0.05.
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changes necessary for increased mitochondrial biogenesis within
HSCs and thus facilitating rapid leukocyte expansion. Further-
more, we identified that increased ROS level mediates PI3 kinase
activation which drives mitochondrial transfer from the microen-
vironment to the HSCs. Overall, these results provide insights into
the bioenergetic changes within the hematopoietic system which
underpin the mammalian response to bacterial infection.
The challenge of infection has been a significant selective
pressure on mammalian evolution and remains a leading global
cause of mortality. Of the top 10 global causes of death in 2016, 3
are infectious or communicable diseases: lower respiratory tract
infection, diarrheal illness, and tuberculosis (13). Faced with the
challenge of infection, the hematopoietic response must be robust
and rapid and result in a massive amplification of myeloid cells
over a short period of time. Neutrophils are the most abundant
leukocyte in mammals and contribute to the resolution of in-
fection through a series of mechanisms including phagocytosis,
enzyme-mediated lysis, capture within neutrophil extracellular
traps, and activation of lymphocytes (30). Neutrophils are used up
in large quantities, and the hematopoietic system rapidly adapts to
the increased demand by switching from steady-state to emergency
granulopoiesis (31). The transition from steady-state to emergency
hematopoiesis is established to involve a complex remodeling and
interplay between hematopoietic and nonhematopoietic cells of
the BM microenvironment mediated by cytokines and growth
factors (32–34) and places a significant metabolic demand on the
hematopoietic system. Moreover, BMSCs have been shown to
enhance hematopoiesis during inflammatory conditions to support
the replenishment of innate effector cells and to prevent the ex-
haustion of the HSC pool (35). Here, we show how mitochondrial
transfer facilitates the rapid onset of emergency hematopoiesis
by allowing an increase in mitochondrial mass and subsequent
metabolic changes in HSCs without the need to “wait” for in-
tracellular increase in mitochondrial biogenesis.
Mitochondrial trafficking between cells is now increasingly
recognized as a fundamental interaction in both malignant and
nonmalignant tissue. Others have reported mitochondrial transfer
from stromal cells to cancer cell lines including to breast (36), lung
(37, 38), and melanoma (39) cells. Moreover, a recent paper by
Bajzikova et al. (40) has shown that cancer cells acquire mitochon-
dria from host stroma to drive OXPHOS-derived dihydroorotate
dehydrogenase pyrimidine synthesis and that this process does not
require mitochondrial ATP. In addition, we have previously shown
how AML-derived NADPH oxidase-2–derived superoxide drives
mitochondrial transfer from BMSCs to leukemic blasts in a paracrine
protumoral mechanism. This transfer of mitochondria promoted
OXPHOS in the tumor cells, and inhibition of NADPH oxidase-2
was able to prevent mitochondrial transfer, increase AML apoptosis,
and improve NSG AML mouse survival (17). However, an inhibitor
of dihydroorotate dehydrogenase, BAY2402234, has been shown to
induce differentiation of AML blasts, which suggests that multiple
cellular functions require import of mitochondria, other than just
OXPHOS-driven ATP production (41).
In the nonmalignant setting, mitochondrial transfer from BM-
derived stromal cells to pulmonary alveoli protects against acute
lung injury (23), and transient focal cerebral ischemia in mice in-
duces entry of astrocytic mitochondria into adjacent neurons,
which amplifies cell survival signals (42). At a similar time, others
reported that BMmicroenvironment myeloid cell-derived NADPH
oxidase-2–derived ROS plays a critical role in mediating emer-
gency granulopoiesis during acute infection (20). Therefore, in
context, our present study identifies ROS-driven protumoral mi-
tochondrial transfer in AML as a process which appears to have
been hijacked from the highly evolved mammalian HSC response
to infection. In doing so, we provide a paradigm to be investigated
Fig. 3. Superoxide drives mitochondrial increase to the HSC. (A) C57/Bl6 mice were infected with S. typhimurium for 72 h, and then 1 × 106 BM cells were
analyzed by Amplex Red assay. (B) C57/Bl6 mice were infected with S. typhimurium for 72 h and analyzed by flow cytometry of H2DCFDA, and fluorescence
was assessed in the HSC populations to quantify ROS levels. (C) C57/Bl6 mice were treated with BSO for 16 h and analyzed by flow cytometry, and H2DCFDA
fluorescence was assessed. (D) C57/Bl6 mice were treated with BSO for 16 h and analyzed by flow cytometry, and MTG fluorescence was assessed. (E)
Schematic diagram of experimental design. Post engraftment hu-NSG mice were injected with BSO for 2 h. The BM was extracted, and the cells were analyzed
by flow cytometry or sorted for hHSC (mCD45−, hCD34+, hCD38−, hCD45RA−, hCD90+, hCD49f+), hMPP (mCD45−, hCD34+, hCD38−, hCD45RA−, hCD90−,
hCD49f−), and hGMP (mCD45−, hCD34+, hCD38+, hCD45RA+, hCD90−, hCD49f−) cell populations using FACS. (F) mtDNA transfer was quantified using
Taqman qPCR with species-specific probes. The graph represents the percentage of mouse mtDNA in the hHSC and hMPP cells after 2 h treatment with LPS
versus control (untreated) cells. Human genomic DNA was used to standardize mtDNA. Data shown are means ± SD of n = 5 mice. *P < 0.05; **P < 0.01.
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in other malignancies which are established to rely on mitochondrial
transfer for tumor growth; such cancers evolve from tissue-specific
stem and progenitor cells which utilize mitochondrial transfer as a
response to injury or cellular stress.
In conclusion, we report that mitochondria are transferred from
the BMSCs into HSCs under the regulation of superoxide in re-
sponse to bacterial infection. Importantly, we have discovered that
mitochondrial transfer occurs before mitochondrial biogenesis in a
system which has evolved in mammals to support the required
rapid granulocytic response to acute bacterial infection.
Materials and Methods
Animals. NOD SCID Il2rg knockout NSG (CD45.1) and B6.SJL-PtprcaPep3b/BoyJ
(CD45.1) mice were purchased from The Jackson Laboratory (Bar Harbor,
ME). C57BL/6J mice (CD45.2), B6.129S-Cybbtm1Din/J mice, and CBA mice were
purchased from Charles River Laboratories. Animals were housed in a spe-
cific pathogen-free facility. All animal work in this study was carried out in
accordance with regulations set by the United Kingdom Home Office and the
Animal Scientific Procedures Act of 1986. Mice were 8 to 12 wk of age (with
the exception of mice that were used for transplantation in which case 3- to
4-wk-old mice were used), and both genders were used for experiments.
Human Cord Blood. HPCs were isolated from cord blood at the Norfolk and
Norwich University Hospital following informed consent and under approval
of the UK NHS Health Research Authority (ref07/H0310/146). The samples
collected were de-identified before use in this study.
Cells. Hematopoietic populations were isolated from mouse BM. Mouse
lineage-negative cells were depleted frommouse BMusing a direct cell lineage
depletion kit. (Miltenyi Biotec). The lineage-negative cells were expanded in
Dulbecco’s Modified Eagle Media (DMEM) containing 10% fetal bovine serum
Fig. 4. BMSCs supply mitochondria to HSCs in response to infection. (A) Schematic diagram of experimental design. CBA lineage-negative cells (recipient)
were cocultured with C57BL/6 bone marrow-derived macrophage cells, BM osteoblasts, and BMSCs (donor) for 24 h with and without H2O2. The lineage-
negative cells were removed and analyzed for PepCboy SNP mtDNA in CBA lineage-negative cells by TaqMan PCR using ND3 probes. (B–D) The percentage of
PepCboy mtDNA in CBA lineage-negative cells after 24 h treatment with H2O2 versus control (untreated) cells using the ND3 TaqMan probe. CBA gDNA was
used to standardize mtDNA copy number. (E) Representative fluorescent microscopy images of lineage-negative cells (white arrow) lentivirally transduced
with the rLV.EF1.AcGFP-Mem9 virus cultured with mBMSCs transduced with rLV.EF1.mCherry-Mito-9 in the absence or presence of 10 μM H2O2 for 24 h. (F)
Quantification of rLV.EF1.mCherry-Mito-9 in lineage-negative cells from images presented is taken from 3 independent experiments and 20 lineage cells from
each experiment (E). (G) Lineage-negative cells cultured with mBMSCs transduced in the absence or presence of 10 μM H2O2 for 24 h and then stained for
Annexin V and analyzed by flow cytometry. (H) Flow cytometry-based analysis of BMSC. (I) Relative ROS in BMSC as measured by H2DCFDA fluorescence. (J)
Mitochondrial content in BMSC as measured by MTG after treatment with NAC and LPS or LPS alone. Data shown are means ± SD of n = 5 mice. *P < 0.05.
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(FBS) plus 1% penicillin-streptomycin supplemented with mSCF (100 ng/mL),
mIL3 (10 ng/mL), and hIL6 (100 ng/mL) (Peptrotech). mBMSCs were isolated
from the mouse BM by adherence to tissue culture plastic and then expanded
in minimum essential media (MEM) containing 20% FBS plus 1% penicillin-
streptomycin. mBMSC markers were confirmed by flow cytometry for ex-
pression of CD105+, CD140a+ CD31−, Ter119−, and CD45−. mBM macro-
phages were isolated by adherence when cultured in MEM containing 20%
FBS plus 1% penicillin-streptomycin supplemented with macrophage colony-
stimulating factor (CSF) (20 ng/mL). The media were refreshed daily until day 3
when the media were replaced with MEM containing 20% FBS plus
1% penicillin-streptomycin supplemented with macrophage CSF (10 ng/mL)
(Peptrotech). Osteoblasts were isolated from mouse BM by adherence when
cultured in MEM containing 20% FBS plus 1% penicillin-streptomycin
supplemented with macrophage CSF (10 ng/mL) (Peptrotech) and Prosta-
glandin E2 (PGE2) (10−7M) (Peptrotech) for 3 d. On day 3 the media were
changed to MEM containing 20% FBS plus 1% penicillin-streptomycin sup-
plemented with macrophage CSF (10 ng/mL), PGE2 (10−7M), and RANKL
(10 ng/mL) (Peptrotech). Human CD34+ cells were enriched from whole cord
blood using CD34+ Magnetic Bead separation (Miltenyi Biotec). Culture of
all hematopoietic populations was carried out in 5% CO2 at 37 °C.
Method Details.
Cell isolation and preparation. BM isolation was prepared by isolating the tibia,
femur, and pelvis of each mouse. The bone was cut in the middle and placed
in a 0.5-mL Eppendorf tube in which a hole was made to allow the removal of
the BM, placed in an intact 1.5-mL Eppendorf tube, and centrifuged on full
power for 6 s to collect the BM cells. The BM pellet from each mouse was
pooled and washed in phosphate buffer solution (PBS), and, where
needed, the red blood cells were lysed using 1× red blood cell lysis buffer
(ThermoFisher, Waltham, MA) and centrifuged at 1,200 × g for 5 min, and
the pellet was resuspended in antibody mixtures in PBS.
Flow cytometry and cell sorting.Antibody mixtures were prepared in 1× PBS and
incubated with BM cells for at least 30 min at 4 °C. In experiments using
MTG, the cells were incubated with MTG (30 nM, Invitrogen) with verapamil
(50 μM, Sigma-Aldrich, St. Louis) at room temperature for 30 min, washed
twice in 1× PBS, and centrifuged at 1,200 × g for 5 min before staining with
antibody mixture. For experiments using H2DCFDA (1 nM, Invitrogen), the
cells were incubated with H2DCFDA at room temperature for 30 min,
washed twice in 1× PBS, and centrifuged at 1,200 × g for 5 min before
staining with antibody mixture. For flow cytometric cell sorting of BM cell
populations, pellet was resuspended in antibody mix, and cells were sorted
directly into lysis buffer. Flow cytometry was carried out using a FACSCanto II
flow cytometer (BD Bioscience), and cell sorting was performed on a BD
FACSMelody (BD Bioscience). Data were analyzed using FlowJo (TreeStar,
Ashland, OR). See Fig. 1B for specific gating strategies.
BM transplantation. For the C57 NSG allograft model (C57NSG), the NSGmouse
model expressing the CD45.1 allele antigen was used in transplant experi-
ments in which isolated lineage-negative BM cells from C57 Bl/6 mice
expressing the CD45.2 allele were transplanted. The 2 × 105 isolated C57BL/6
lineage-negative BM cells were then injected into the tail vein of non-
irradiated 3- to 4-wk-old NSG mice. Engraftment of the C57BL/6 BM was
analyzed by flow cytometry through analysis of CD45.2 cells in the periph-
eral blood. These animals were then treated with 1 mg/kg LPS or control PBS
for 2 h and killed by exposure to CO2. BM was isolated and sorted for donor
LSK (Lin−, Sca-1+, c-Kit) and donor HSC (Lin− Sca-1+ c-Kit CD48−CD150+).
For the CD34+ hematopoietic progenitor cell xenograft model (hu-NSG), 2 ×
105 CD34+ cord blood cells were injected into the tail vein of nonirradiated 3-
to 4-wk-old female NSG mice. CD34+ cell engraftment was monitored by
peripheral blood analysis for human CD45 cells. At 12 wk post injection, mice
were treated with 1 mg/kg LPS for 2 h and killed by exposure to CO2. BM was
harvested, and cell sorting was performed for human HSCs (hHSCs) (mCD45−,
hCD34+, hCD38−, hCD45RA−, hCD90+, hCD49f+), hMPPs (mCD45-, hCD34+,
Fig. 5. Connexin channels regulate mitochondrial movement from BMSCs to HSCs. (A) Flow cytometry-based analysis of lineage-negative cells cocultured
with mBMSC stained with calcein. The cocultures were treated with 10 μM H2O2 or carbenoxolone and 10 μM H2O2 for 24 h, and the lineage-negative cells
were removed and analyzed for calcein mean fluorescence intensity (MFI). (B) CBA-derived lineage-negative cells and PepCboy-derived BMSCs were cocul-
tured with H2O2 or carbenoxolone and 10 μM H2O2 for 24 h. The lineage-negative cells were removed and analyzed for C57BL/6 SNP mtDNA in CBA lineage-
negative cells by TaqMan PCR using ND3 probes. (C) C57BL/6 mice were subjected to carbenoxolone (CBX) pretreatment before LPS or control PBS i.p. in-
jections. After 2 h the mice were killed, and the BM was extracted. The populations were analyzed by flow cytometry for mean MTG fluorescence intensity
within each population. (D) Immunofluorescent staining of CX43 of lineage-negative cells and BMSCs cocultured with 10 μM H2O2 with and without pre-
treatment with GAP27 (100 μM). (Magnification: D, 63×.) (E) Quantification of images shown in E numbers of lineage-negative cells positive for mito-9
mCherry. (F) CBA lineage-negative cells cocultured with C57 mBMSC. The cocultures were treated with 10 μM H2O2 or GAP27 (100 μM) for 24 h, and the
lineage-negative cells were removed and analyzed for SNP mtDNA in CBA lineage-negative cells by TaqMan PCR using ND3 probes. *P < 0.05.
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hCD38−, hCD45RA−, hCD90−, hCD49f−), and hGMPs (mCD45−, hCD34+,
hCD38+, hCD45RA+, hCD90−, hCD49f−). BM was also analyzed for human cell
engraftment by human CD45+ cells. If more than 1% of human CD45 cells was
detected in the BM, the CD34+ cells were determined to be engrafted.
mtDNA quantification. DNA was extracted from sorted or cultured hemato-
poietic populations using the GenElute Mammalian Genomic DNA Miniprep
Kit (Sigma Aldrich, St. Louis) according to the manufacturer’s instructions.
For the C57NSG model and coculture experiments, relative quantitative
real-time PCR using the Taqman probes ND3 and COX3 (ThermoFisher) was
performed on the purified DNA. ND3 and COX3 Taqman assays were run in
simplex reactions, and master mixes were generated. One microliter of
Taqman assay (containing primers and probe) was mixed with 2.5 μL of
TaqPath ProAmp enzyme (ThermoFisher) and 1.5 μL of water. After pre-
amplification (60 ̊C for 30 s and 95 ̊C for 5 min), the PCRs were amplified for
50 cycles (95 ̊C for 15 s and 60 ̊C for 1 min) and cooled (40 ̊C for 30 s) on a 384-
well LightCycler 480 (Roche, Burgess Hill, UK). Each mtDNA level was nor-
malized against the genomic DNA (gDNA). The relative mtDNA:gDNA ratio
was calculated using the ΔΔCt method.
In the hu-NSG model, predesigned Taqman assays were obtained from
(ThermoFisher), encompassing both human and mouse mtDNA and gDNA.
The human and mouse mtDNA Taqman assays were run in duplex reactions.
The human and mouse gDNA Taqman assays were ran in simplex reactions,
and simplex and duplexmaster mixes were generated. For the simplex master
mix, 1 μL of Taqman assay (containing primers and probe) was mixed with
2.5 μL of TaqPath ProAmp enzyme (ThermoFisher) and 1.5 μL water. For the
duplex master mix, 0.5 μL of each Taqman assay (total 1 μL) was mixed with
2.5 μL of TaqPath ProAmp enzyme and 1.5 μL water. This master mix (5 μL)
was then added to the DNA (1 μL) on the PCR plate. The PCR plate was sealed,
centrifuged at 1,000 × g for 1 min and loaded into the Lightcycler using the
program previously described. mtDNA copy numbers were determined for
both human and mouse mitochondria applying the ΔΔCt method, using hu-
man genomic telomerase reverse transcriptase to normalize results. These
values were used to generate the percentage of mouse mitochondria in the
human cells to quantify mitochondrial transfer.
Amplex Red superoxide detection assay. Amplex Red superoxide detection assay
(ThermoFisher) was used to specifically measure the superoxide levels gener-
ated. This reaction was carried out per the manufacturer’s specifications. BM
was plated on a black 96-well plate with a transparent base in a volume of
50 μL FluoroBrite DMEM supplemented with 10% FCS. Amaster mix was created
by mixing 0.5 μL Amplex Red reagent, 1 μL horseradish peroxidase, and 48.5 μL
1× reaction buffer per sample. Fifty microliters of this master mix was added to
the cell suspension, and fluorescence was measured using the FLUOstar
Omega microplate reader (BMG LABTECH, Ortenberg, Germany). A hydrogen
peroxide standard curve was performed on each 96-well plate measured to
determine an accurate superoxide concentration in the samples tested.
Coculture experiments.mBMSCs, mBM osteoblasts, or mBMmacrophages were
seeded in a 24-well plate in normal growthmedia. Once 70% confluent 0.25 ×
106 lineage-negative cells were then cocultured with the mBM cells in the
absence or presence of H2O2 for 24 h and the CX43 peptide inhibitor GAP27.
Lineage-negative cells were removed and sorted for CD45-specific markers
Fig. 6. ROS-derived pAKT drives mitochondrial transfer. (A) C57BL/6 mice were subjected to LPS or control PBS i.p. injections. After 2 h the mice were killed,
and the BM extracted. BMSCs (A) and HSCs (B) were analyzed by flow cytometry for pAKT. (C) C57BL/6 mice were subjected to BSO or control PBS i.p. in-
jections. After 2 h the mice were killed, and the BM was extracted. BMSCs and HSCs were analyzed by flow cytometry for pAKT. (D) Western bot analysis of
lineage-negative cells cocultured with mBMSCs. The cocultures were treated with 10 μM H2O2 for 30 min, and the lineage-negative cells were removed and
analyzed for pAKT expression. (E and F) Flow cytometry-based analysis of lineage-negative cells cocultured with mBMSCs stained with calcein. The cocultures
were treated with 10 μM H2O2 or CAL-101 and H2O2 for 24 h, and the lineage-negative cells were removed and analyzed for calcein MFI (E) or (F) for SNP
mtDNA in CBA lineage-negative cells by TaqMan PCR using ND3 probes. (G) C57BL/6 mice were subjected to LPS with or without pretreatment with CAL-101
or control PBS i.p. injections. After 2 h the mice were killed, and the BM was extracted. HSCs were analyzed for mitochondrial content using MTG. (H and I)
C57/Bl6 mice were infected with S. typhimurium and then split into 2 groups. The first group received vehicle control and the test group received a daily dose
of CAL-101 (30 mg/kg) by oral gavage. Animals were killed on day 5, and livers were isolated and analyzed for CFUs/mg of tissue and sectioned and stained
with hematoxylin and eosin. (Magnification: H, 63×.) *P < 0.05.
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into cell lysis solution. DNA was extracted, and mtDNA quantification was
performed using qPCR.
Immunofluorescence. mBMSCs were isolated from the bone morrow as pre-
viously described and seeded at a density of 5 × 105 BMSCs in 500 μL of
penicillin-streptomycin–free DMEM supplemented with 10% FCS. A total of
0.5 μL of the rLV.EF1.mCherry-Mito-9 lentivirus (Clontech Takara Bio Europe,
Saint-Germain-en-Laye, France) (0.5 × 106 virus particles) was added to the
medium. One milliliter of DMEM was added after 24 h, and mBMSCs were
cultured for a further week to ensure that no residual lentivirus remained.
Successful transduction was assessed by the detection of mCherry fluorescence
in the mBMSCs by fluorescent microscopy. In addition, the rLV.EF1.AcGFP-
Mem9 lentivirus was purchased from Clontech Takara Bio Europe, enabling
the stable tagging of plasma membranes with a green fluorescent protein
(GFP) fluorophore. Mouse lineage-negative cells were depleted from mouse
BM using a direct cell lineage depletion kit (Miltenyi Biotec), and cells were
transduced with this lentivirus and cultured for 72 h prior to use. Successful
transduction was assessed by the detection of GFP fluorescence in the lineage-
negative cells by fluorescent microscopy. If successful transduction was ob-
served, mBMSCs were seeded at 5 × 104 cells per well of a 24-well plate on
tissue culture coverslips coated with 1 μg/mL poly-D-lysine (Sigma-Aldrich).
Transduced lineage-negative cells (0.25 × 106) were then cocultured with the
mBMSCs for 24 h in the absence or presence of H2O2. Cells were fixed in 4%
paraformaldehyde and stained for 15 min in DAPI (ThermoFisher). After
washing 3 times with 1× PBS, cells were mounted with mounting media
(ThermoFisher). Immunofluorescent images were acquired with a Zeiss Axioplan
2ie microscope. Confocal images were acquired on Zeiss LSM 800 Axio
Observer.Z1 confocal microscope with a 63× water objective (Carl Zeiss).
Seahorse.XFp flux cartridgeswere hydrated in XF Calibrant overnight at 37 °C.
LSK cells were isolated from the bone marrow of 2 mice, and 2 mice were
treated either with LPS or PBS by fluorescence-activated cell sorting (FACS)
into conventional Seahorse base media. A total of 50,000 cells were plated
onto one well of a Seahorse XFp culture plate coated with poly-D-lysine and
centrifuged briefly to achieve a uniform monolayer of cells. Cells were
equilibrated in a humidified non-CO2 incubator until the start of the assay.
Flux cartridges were loaded with Oligomycin (2 μM), carbonyl cyanide-4-
(trifluoromethoxy) phenylhydrazone (1 μM), and Rotenone (0.5 μM)
according to the manufacturer’s instructions. Oxygen consumption rate and
basal extracellular acidification rate values were obtained using the XFp
Mito Stress Kit. Metabolic parameters were derived from calculations based
on the manufacturer’s instructions. All results were normalized to input cell
number. Due to the feasibility of cell number isolation, experiments are
represented as one replicate per cell type, per condition.
S. typhimurium and LPS elicited stressed hematopoiesis. Glycerol stock of S.
typhimurium (SL1344-JH3009) was a kind gift from Isabelle Hautefort,
Quadram Institute Bioscience, Norwich, United Kingdom. The stock was
plated on Luria Broth agar plates, and the colonies were inoculated and
grown overnight in 5 mL of Luria Broth with 0.3 M NaCl (LBS). The overnight
culture was then diluted 1:100 in LBS and grown until the culture optical
density (ΔOD600nm) of 1.2 to 1.4 (late exponential phase). This is the time
point at which SPI1 invasion genes are turned on in S. typhimurium. The
bacterial culture was then centrifuged at 8,000 × g for 7 min before washing
bacterial cells twice in 25 mL of sterile Dulbecco’s phosphate-buffered saline
(DPBS) at room temperature. Finally, we resuspended the bacterial cells in
sterile DPBS at concentration of 1 to 5 × 108 CFUs per 100 μL of DPBS
(knowing that ΔOD600nm 1.26 corresponds to 7.53 × 108 CFUs/mL).
C57BL/6 mice were treated with streptomycin (20 mg/mL) 24 h prior to S.
typhimurium infection. Mice were then left untreated or infected with 100 μL
of 1 × 108 CFUs of S. typhimurium (SL1344-JH3009) by oral gavage for 72 h.
C57BL/6 mice, CGD mice, or Hu-NSG mice were treated with LPS or control PBS
for 2 or 16 h. The mice were killed by exposure to CO2, and the BM was an-
alyzed by flow cytometry and cell sorting.
Analysis of ROS in vivo. C57BL/6 mice were treated with 100 mg/kg BSO for 2 h
and killed by exposure to CO2. The BM was extracted for flow cytometry-
based lineage analysis. C57BL/6 mice were also pretreated with 500 mg/kg
NAC for 1 h, followed by 1 mg/kg LPS, and after 2 h the mice were killed, and
the BM was extracted for flow cytometry-based lineage analysis. The BM was
extracted for flow cytometry-based lineage analysis of the LSK and HSC
populations for mean MTG intensity as a measure for mitochondrial content
and H2DCFDA as a measure of ROS.
Real-time PCR for mitochondrial biogenesis genes. The ReliaPrep RNA cell miniprep
system (Promega, Southampton, UK)was used to extract whole-cell RNA. Nugen
PicoSL WTA (Redwood City, CA) was used to generate first-strand, followed by
double-strand complementary DNA (cDNA), followed by cDNA amplification. A
qRT-PCR assaywas performedwith the SYBR-green technology (PCRBiosystems).
PCRs were amplified for 45 cycles (95 °C/15 s, 60 °C/10 s, 72 °C/10 s), after pre-
amplification (95 °C/60 s), on a Roche 384-well/96-well LightCycler480. mRNA
expression was normalized against glyceraldehyde 3-phosphate dehydrogenase
using the comparative cycle threshold method.
Granulocyte and monocyte CFUs. BM cells (1 × 104) from control and LPS-treated
mice were seeded in a semisolid Methocult (Stemcell Technologies, Cam-
bridge, UK) containing penicillin-streptomycin for detection of granulocytes,
granulocyte monocytes, granulocyte monocyte megakaryocytes. After 1 wk
of culture colony types were counted per well.
Bacterial CFUs and liver histology. Livers were homogenized in sterile PBS so-
lution and plated in LB agar plates for 24 h, after which colonies were
counted. Data are shown in CFUs relative to milligrams of liver tissue. Liver
tissues were fixed in neutral formalin for 24 h and embedded afterward in
paraffin blocks that were further sectioned, dewaxed, and hydrated. Slides
were stained with hematoxylin and eosin for histopathological analysis.
Quantification and Statistical Analysis. For statistical comparison of 2 groups,
unpaired two-tailed Student’s t test was used. When more than 2 groups
were compared, one-way ANOVA followed by Kruskal–Wallis test was per-
formed using Prism version 7.00 for Windows (GraphPad, La Jolla, CA). Due
to variability in the data, statistical comparison of in vivo work was per-
formed without assumption of normal distribution using the Mann–Whitney
U test. Differences among group means were considered significant when
the probability value, P, was less than 0.05*, 0.01**, or 0.001***. Sample size
(n) represents the number of biological replicates. No statistical methods
were used to predetermine sample size.
Data Availability Statement. All relevant data are within the manuscript and
its supporting information files. The sequences for the mitochondrial SNP
analysis are in ref. 43.
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